Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease

Table 3 Results of correlation analysis

		BNP	ANP	Cholesterol	HDL-C	LDL-C	Triglyceride	VLDL
LA/Ao	r	.836^a	.770^a	.455^b	−.361	.516^a	.050	.050
LA/Ao	p	.000	.000	.013	.054	.004	.796	.796
LVIDd	r	.510^a	.457^b	.628^a	-.414^b	.689^a	.067	.067
LVIDd	p	.005	.013	.000	.025	.000	.729	.729
LVIDdBW	r	.564^a	.548^a	.606^a	-.407^b	.660^a	.169	.169
LVIDdBW	p	.002	.003	.001	.035	.000	.400	.400
VHS	r	.813^a	.760^a	.492^a	-.445^b	.584^a	−.063	−.063
VHS	p	.000	.000	.008	.018	.001	.750	.750
BNP	r	1	.880^a	.366^b	-.620^a	.503^a	−.068	−.068
BNP	p		.000	.033	.000	.002	.702	.702
ANP	r	.880^a	1	.322	-.510^a	.413^b	.132	.132
ANP	p	.000		.064	.002	.015	.455	.455
Cholesterol	r	.366^b	.322	1	−.276	.947^a	.085	.085
Cholesterol	p	.033	.064		.115	.000	.634	.634
Triglyceride	r	−.068	.132	.085	.318	−.117	1	1.000^a
Triglyceride	p	.702	.455	.634	.066	.510		.000
VLDL	r	−.068	.132	.085	.318	−.117	1.000^a	1
VLDL	p	.702	.455	.634	.066	.510	.000
HDL-C	r	-.620^a	-.510^a	−.276	1	-.557^a	.318	.318
HDL-C	p	.000	.002	.115		.001	.066	.066
LDL-C	r	.503^a	.413^b	.947^a	-.557^a	1	−.117	−.117
LDL-C	p	.002	.015	.000	.001		.510	.510

^aCorrelation is significant at the 0.01 level, ^bCorrelation is significant at the 0.05 level
MMVD Myxomatous mitral valve disease, LA/AO Left atrium/aorta ratio, LVIDd Left ventricular end- diastolic diameter in diastole, LVIDdN Left ventricular end- diastolic diameter normalized for body weight, VHS Vertebral heart score. HDL-C High density lipoprotein, LDL-C Low-density lipoprotein, VLDL Very low-density lipoprotein, BNP B-type natriuretic peptide, ANP Atrial natriuretic peptide

ISSN: 1746-6148